Japan Pharmaceutical Logistics Market Forecast 2024-2032

The Japan pharmaceutical logistics market is approximated to develop at a CAGR of 8.62% during the forecast period 2024-2032. Different enablers boost market growth, like the rising need for temperature-controlled solutions in pharmaceuticals, the expansion of ocean freight services in the pharmaceutical industry, the rise in consumer preference for over-the-counter medicines, and the surge in pharmaceutical logistics during the Japan COVID-19 pandemic.

MARKET INSIGHTS

The Japan pharmaceutical logistics market is witnessing several key trends that are shaping the industry landscape. One notable trend is the rising need for temperature-controlled solutions in pharmaceuticals. This trend is driven by the growing demand for maintaining the integrity of temperature-sensitive medications, vaccines, and biologics throughout the supply chain. With strict regulatory requirements and the importance of ensuring product efficacy and safety, pharmaceutical companies and logistics providers in Japan are increasingly investing in advanced cold chain infrastructure and technologies to meet these demands.

Additionally, there is a notable expansion of ocean freight services in the pharmaceutical industry in Japan. This expansion reflects the globalization of pharmaceutical supply chains, with an emphasis on cost-effective and efficient transportation solutions. Ocean freight offers advantages such as large cargo capacity, lower transportation costs compared to air freight, and improved accessibility to global markets. As pharmaceutical companies in Japan seek to expand their reach and optimize logistics costs, ocean freight services play a crucial role in supporting their supply chain strategies.

Another significant trend is the rise in consumer preference for over-the-counter (OTC) medicines in Japan. This shift in consumer behavior is influenced by factors such as increased awareness of self-care, convenience in accessing OTC products, and a growing emphasis on preventive healthcare. As a result, there is a surge in demand for logistics services that cater to the distribution of OTC medicines, including efficient inventory management, timely deliveries to retail outlets, and adherence to regulatory guidelines for OTC product handling. This trend underscores the evolving dynamics of the pharmaceutical logistics market in Japan, where meeting consumer preferences and ensuring supply chain efficiency are key priorities for industry stakeholders.

COMPETITIVE INSIGHTS

Some of the major companies in the Japan pharmaceutical logistics market include DB Schenker, Deutsche Post AG, DSV, FedEx, Kuehne + Nagel, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors such as market share.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 85205

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.6. MAJOR MARKET FINDINGS
- 2.6.1. BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.2. COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
- 2.6.3. COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.4. MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
- 3.1.2. EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
- 3.1.3. RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
- 3.1.4. SURGE IN PHARMACEUTICAL LOGISTICS DURING THE JAPAN COVID-19 PANDEMIC
3.2. KEY RESTRAINTS
- 3.2.1. RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
- 3.2.2. ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
- 4.1.2. REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
- 4.1.3. INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR JAPAN
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS
- 4.5.1. MANUFACTURING
- 4.5.2. STORAGE
- 4.5.3. TRANSPORTATION
- 4.5.4. DISTRIBUTION
- 4.5.5. MONITORING COMPONENTS
- 4.5.6. CONSUMPTION
4.6. KEY BUYING CRITERIA
- 4.6.1. TYPE OF LOGISTICS
- 4.6.2. SERVICES OFFERED
- 4.6.3. MODE OF TRANSPORTATION
- 4.6.4. APPLICATION
- 4.6.5. REGULATORY COMPLIANCE
- 4.6.6. TECHNOLOGICAL CAPABILITIES
- 4.6.7. COST
- 4.6.8. RELIABILITY
- 4.6.9. AGILITY

5. MARKET BY PRODUCT

5.1. BRANDED DRUGS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. GENERIC DRUGS
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. OTC
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY THERAPY AREA

6.1. COMMUNICABLE DISEASES
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ONCOLOGY
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. DIABETES
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS
6.4. CARDIOVASCULAR DISEASES
- 6.4.1. MARKET FORECAST FIGURE
- 6.4.2. SEGMENT ANALYSIS
6.5. AUTOIMMUNE DISEASES
- 6.5.1. MARKET FORECAST FIGURE
- 6.5.2. SEGMENT ANALYSIS
6.6. NEUROLOGICAL DISORDERS
- 6.6.1. MARKET FORECAST FIGURE
- 6.6.2. SEGMENT ANALYSIS
6.7. PAIN MANAGEMENT
- 6.7.1. MARKET FORECAST FIGURE
- 6.7.2. SEGMENT ANALYSIS
6.8. RESPIRATORY DISEASES
- 6.8.1. MARKET FORECAST FIGURE
- 6.8.2. SEGMENT ANALYSIS
6.9. OTHER THERAPY AREAS
- 6.9.1. MARKET FORECAST FIGURE
- 6.9.2. SEGMENT ANALYSIS

7. MARKET BY TYPE

7.1. NON-COLD CHAIN LOGISTICS
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. COLD CHAIN LOGISTICS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS

8. MARKET BY COMPONENT

8.1. STORAGE
- 8.1.1. WAREHOUSE
  - 8.1.1.1. MARKET FORECAST FIGURE
  - 8.1.1.2. SEGMENT ANALYSIS
- 8.1.2. REFRIGERATED CONTAINERS
  - 8.1.2.1. MARKET FORECAST FIGURE
  - 8.1.2.2. SEGMENT ANALYSIS
8.2. TRANSPORTATION
- 8.2.1. OVERLAND LOGISTICS
  - 8.2.1.1. MARKET FORECAST FIGURE
  - 8.2.1.2. SEGMENT ANALYSIS
- 8.2.2. SEA FREIGHT LOGISTICS
  - 8.2.2.1. MARKET FORECAST FIGURE
  - 8.2.2.2. SEGMENT ANALYSIS
- 8.2.3. AIR FREIGHT LOGISTICS
  - 8.2.3.1. MARKET FORECAST FIGURE
  - 8.2.3.2. SEGMENT ANALYSIS
8.3. MONITORING COMPONENTS
- 8.3.1. HARDWARE
  - 8.3.1.1. SENSORS
  - 8.3.1.1.1. MARKET FORECAST FIGURE
  - 8.3.1.1.2. SEGMENT ANALYSIS
  - 8.3.1.2. RFID DEVICES
  - 8.3.1.2.1. MARKET FORECAST FIGURE
  - 8.3.1.2.2. SEGMENT ANALYSIS
  - 8.3.1.3. TELEMATICS
  - 8.3.1.3.1. MARKET FORECAST FIGURE
  - 8.3.1.3.2. SEGMENT ANALYSIS
  - 8.3.1.4. NETWORKING DEVICES
  - 8.3.1.4.1. MARKET FORECAST FIGURE
  - 8.3.1.4.2. SEGMENT ANALYSIS
- 8.3.2. SOFTWARE
  - 8.3.2.1. MARKET FORECAST FIGURE
  - 8.3.2.2. SEGMENT ANALYSIS

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. AP MOLLER - MAERSK
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT PORTFOLIO
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. CARDINAL HEALTH
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT PORTFOLIO
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. CEVA LOGISTICS
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT PORTFOLIO
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. DB SCHENKER
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT PORTFOLIO
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. DEUTSCHE POST AG
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT PORTFOLIO
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. DSV
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT PORTFOLIO
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. FEDEX
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT PORTFOLIO
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. KUEHNE + NAGEL
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT PORTFOLIO
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. MEDLINE
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT PORTFOLIO
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. SEKO LOGISTICS
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT PORTFOLIO
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. UNITED PARCEL SERVICE (UPS)
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT PORTFOLIO
  - 9.2.11.3. STRENGTHS & CHALLENGES

Product Code: 85205

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL LOGISTICS
TABLE 2: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: JAPAN STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: JAPAN STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: JAPAN TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: JAPAN TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: JAPAN MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: JAPAN MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: JAPAN HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: JAPAN HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 8: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 9: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 11: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023
FIGURE 12: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 13: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 15: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 16: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 17: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)
FIGURE 18: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 19: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 20: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)
FIGURE 21: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 22: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 23: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 24: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023
FIGURE 25: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 26: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)
FIGURE 27: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)
FIGURE 28: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 29: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 30: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 31: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 32: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)
FIGURE 33: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 34: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)
FIGURE 35: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 36: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)
FIGURE 37: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 38: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)